Jin-long Chen, Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 101,530 shares at $12.99 ($1.3M) on 2019-10-31, disclosed to the SEC on 2019-11-04.
Open-market sale of $1.3M NGM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 28,376 | $369K | 28.1% |
| 2 | $12.99 | 28,376 | $369K | 28.1% |
| 3 | $13.29 | 11,403 | $152K | 11.6% |
| 4 | $13.29 | 11,403 | $152K | 11.6% |
| 5 | $12.26 | 10,986 | $135K | 10.3% |
| 6 | $12.26 | 10,986 |
| $135K |
| 10.3% |
| Total | $12.90 avg | 101,530 | $1.3M | 100% |
| Filing → |
| NGM | SELL | 2021-11-16 | $592K | — | Filing → |
| NGM | SELL | 2021-10-13 | $608K | — | Filing → |
| NGM | SELL | 2021-09-14 | $1.5M | — | Filing → |